BACKGROUND AND OBJECTIVE: Skull base chordomas are clinically malignant because of the difficulty of total removal, high recurrence rate, and occasional drop metastasis. Although aggressive surgical resection and postoperative radiation have been recommended, the long-term outcome remains unsatisfactory. METHODS: From 1992 to 2011, we treated 24 patients with skull base chordoma using aggressive surgical removal as a principal strategy. Skull base approaches were selected according to tumor extension to remove the tumor and surrounding bone as completely as possible. After surgery, all patients were closely observed with MRI to find small and localized recurrent tumors, which were treated with gamma-knife radiosurgery or surgical resection. The mean postoperative follow-up duration was 10.2 years (range, 1-17.2 years). RESULTS: The 5-, 10-, and 15-year overall survival rates were 86%, 72%, and 72%, respectively. The 5- and 10-year progression-free survival rates were 47% and 35%, respectively. Tumor extension to the brainstem and partial tumor removal were the factors related to poor survival. CONCLUSIONS: Our results suggest that aggressive surgical removal improves the long-term outcome of patients with skull base chordoma. We would like to emphasize that skull base chordomas should be aggressively removed using various skull base approaches.
BACKGROUND AND OBJECTIVE: Skull base chordomas are clinically malignant because of the difficulty of total removal, high recurrence rate, and occasional drop metastasis. Although aggressive surgical resection and postoperative radiation have been recommended, the long-term outcome remains unsatisfactory. METHODS: From 1992 to 2011, we treated 24 patients with skull base chordoma using aggressive surgical removal as a principal strategy. Skull base approaches were selected according to tumor extension to remove the tumor and surrounding bone as completely as possible. After surgery, all patients were closely observed with MRI to find small and localized recurrent tumors, which were treated with gamma-knife radiosurgery or surgical resection. The mean postoperative follow-up duration was 10.2 years (range, 1-17.2 years). RESULTS: The 5-, 10-, and 15-year overall survival rates were 86%, 72%, and 72%, respectively. The 5- and 10-year progression-free survival rates were 47% and 35%, respectively. Tumor extension to the brainstem and partial tumor removal were the factors related to poor survival. CONCLUSIONS: Our results suggest that aggressive surgical removal improves the long-term outcome of patients with skull base chordoma. We would like to emphasize that skull base chordomas should be aggressively removed using various skull base approaches.
Authors: Maria Koutourousiou; Paul A Gardner; Matthew J Tormenti; Stephanie L Henry; Susan T Stefko; Amin B Kassam; Juan C Fernandez-Miranda; Carl H Snyderman Journal: Neurosurgery Date: 2012-09 Impact factor: 4.654
Authors: Hideyuki Kano; Fawaad O Iqbal; Jason Sheehan; David Mathieu; Zachary A Seymour; Ajay Niranjan; John C Flickinger; Douglas Kondziolka; Bruce E Pollock; Gail Rosseau; Penny K Sneed; Michael W McDermott; L Dade Lunsford Journal: Neurosurgery Date: 2011-02 Impact factor: 4.654
Authors: E B Hug; L N Loredo; J D Slater; A DeVries; R I Grove; R A Schaefer; A E Rosenberg; J M Slater Journal: J Neurosurg Date: 1999-09 Impact factor: 5.115
Authors: Maria Koutourousiou; Carl H Snyderman; Juan Fernandez-Miranda; Paul A Gardner Journal: Otolaryngol Clin North Am Date: 2011-07-21 Impact factor: 3.346
Authors: A Terahara; A Niemierko; M Goitein; D Finkelstein; E Hug; N Liebsch; D O'Farrell; S Lyons; J Munzenrider Journal: Int J Radiat Oncol Biol Phys Date: 1999-09-01 Impact factor: 7.038
Authors: Anna V Nikoghosyan; Irini Karapanagiotou-Schenkel; Marc W Münter; Alexandra D Jensen; Stephanie E Combs; Jürgen Debus Journal: BMC Cancer Date: 2010-11-05 Impact factor: 4.430
Authors: Alexey N Shkarubo; Konstantin V Koval; Ilia V Chernov; Dmitry N Andreev; Alexey B Kurnosov; Andrey A Panteleyev Journal: Chin Neurosurg J Date: 2018-11-15
Authors: Kurtis Young; Torbjoern Nielsen; Hannah Bulosan; Tyler J Thorne; Christian T Ogasawara; Andrew C Birkeland; Dennis M Tang; Arthur W Wu; Toby O Steele Journal: Laryngoscope Investig Otolaryngol Date: 2022-09-09